0.00
100.00%
-0.661
Acorda Therapeutics Inc Borsa (ACOR) Ultime notizie
Acorda: Q1 Earnings Snapshot - Milford Mirror
Milford Mirror
Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 - Marketscreener.com
Marketscreener.com
Acorda Therapeutics (NASDAQ:ACOR) Earns Buy Rating from Analysts at StockNews.com - Defense World
Defense World
Acorda (ACOR) Q4 Earnings and Revenues Surpass Estimates - Yahoo Canada Shine On
Yahoo Canada Shine On
Progressive Supranuclear Palsy Therapeutics Market Size and Shar - NEWS CHANNEL NEBRASKA
NEWS CHANNEL NEBRASKA
Acorda Therapeutics (ACOR) Reports Q2 Loss, Tops Revenue Estimates - Yahoo New Zealand News
Yahoo New Zealand News
Acorda Therapeutics (ACOR) Outpaces Stock Market Gains: What You Should Know - Yahoo Movies Canada
Yahoo Movies Canada
Acorda Therapeutics Strikes Creditor Deal On Ch. 11 Loan - Law360
Law360
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket - Markets Insider
Markets Insider
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
UPDATED: Acorda inks $185M asset sale to Merz, files for bankruptcy after years of disappointing sales - FiercePharma
FiercePharma
Acorda Pharmaceuticals in Rockland County NY to shut; 97 jobs lost - The Journal News
The Journal News
Acorda seeks buyer as neurological drug sales fall - Westfair Online
Westfair Online
Pearl River biotech firm up for sale after filing for bankruptcy - Crain's New York Business
Crain's New York Business
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Benzinga
Acorda Joins Growing Group of Biotechs Filing for Bankruptcy, Divests Assets to Merz - BioSpace
BioSpace
Nasdaq Down Over 1%; VivoPower International Shares Spike Higher
Benzinga
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Crude Oil Surges Over 1%; US Factory Orders Increase In February
Benzinga
Dow Dips Over 400 Points; Paychex Posts Downbeat Sales
Benzinga
Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Benzinga
Acorda Therapeutics' Strategic Bankruptcy and Asset Sale Plan - TipRanks.com - TipRanks
TipRanks
Nasdaq Down Over 1%; VivoPower International Shares Spike Higher - Gritstone Bio (NASDAQ:GRTS) - Benzinga
Benzinga
Stocks to Watch: PVH, Canoo, Acorda Therapeutics - MarketWatch
MarketWatch
Health Check: How Prudently Does Acorda Therapeutics (NASDAQ:ACOR) Use Debt? - Simply Wall St
Simply Wall St
Easy-to-use inhaled levodopa system readying request for US... - Parkinson's News Today
Parkinson's News Today
Acorda taking over global sales of Ampyra and Fampyra for MS - Multiple Sclerosis News Today
Multiple Sclerosis News Today
Biogen Bows Out of Acorda Pact on MS Med; Focus Turns to New Growth Drivers - MedCity News
MedCity News
ORGO: 3 Biotech Stocks to Keep an Eye on in 2024 - StockNews.com
StockNews.com
ACOR: Moderna (MRNA) and Acorda Therapeutics (ACOR): Buy, Hold, or Sell in 2024? - StockNews.com
StockNews.com
Acorda Therapeutics Reports Third Quarter 2023 Financial Results - Business Wire
Business Wire
6 Latin American countries asked to OK Inbrija for Parkinson's off... - Parkinson's News Today
Parkinson's News Today
Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American ... - Yahoo Finance
Yahoo Finance
SGIOY: 3 Biotech Stocks to Buy under $20 - StockNews.com
StockNews.com
Acorda Therapeutics (ACOR): A Comprehensive Analysis of Its Market Value - Yahoo Finance
Yahoo Finance
Acorda launches new campaign, website for Inbrija for Parkinson's... - Parkinson's News Today
Parkinson's News Today
Acorda Therapeutics Announces Launch of New INBRIJA® Campaign: "For The Fighters™" - Yahoo Finance
Yahoo Finance
Acorda, Chance sign deals to commercialise INBRIJA in China - Pharmaceutical Technology
Pharmaceutical Technology
Acorda Therapeutics and Chance Pharmaceuticals Announce Agreement to Commercialize INBRIJA® in China - Business Wire
Business Wire
Inbrija, inhaled levodopa for Parkinson's off periods, arrives in... - Parkinson's News Today
Parkinson's News Today
Who are the leading innovators in cancer monoclonal antibody therapy for the pharmaceutical industry? - Pharmaceutical Technology
Pharmaceutical Technology
Acorda Says It's Owed $65M More In MS Drug Fight - Law360
Law360
Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket By Benzinga - Investing.com UK
Investing.com UK
Acorda Therapeutics Announces $16.5M Award and Royalty/Supply Relief in AMPYRA® Arbitration Case - Business Wire
Business Wire
Acorda Therapeutics Chief Operating Officer Lauren Sabella to Retire - citybiz
citybiz
ACOR stock surges 50% on Parkinson's disease drug launch (NASDAQ:ACOR) - Seeking Alpha
Seeking Alpha
Muscle Spasticity Market Huge Growth in Future Scope 2022-2028 | - openPR
openPR
Capitalizzazione:
|
Volume (24 ore):